Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy — Gregg L. Friedman (2012) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Shared by
Gregg L. Friedman
Johns Hopkins University
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Article
2012
en
Authors
Gregg L. Friedman
Johns Hopkins University
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2022
Hypoxia-inducible factors: cancer progression and clinical translation
Elizabeth E. Wicks
,
Gregg L. Friedman
Article
2016
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Luana Schito
,
Gregg L. Friedman
Article
2025
Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy
Gregg L. Friedman
Article
2022
Hypoxia-inducible factors: roles in cardiovascular disease progression, prevention, and treatment
Gregg L. Friedman
Article
2022
Hypoxia and Hypoxia-Inducible Factors in Lymphedema
Xinguo Jiang
,
Wen Tian
,
Dong-Eon Kim
,
Alexander McQuiston
,
Ryan Vinh
,
Stanley G. Rockson
,
Gregg L. Friedman
,
Mark R. Nicolls
Discussion(0)
No comments yet. Be the first to comment.